MRNA Stock Down 3%, Moderna Prices New Shares at $76, Wants to Raise $1.34 Billion

Coinspeaker
MRNA Stock Down 3%, Moderna Prices New Shares at $76, Wants to Raise $1.34 Billion

On Monday, Moderna (MRNA) stock price jumped 20% after the company reported a positive date for its early-stage human trial for the COVID-19 vaccine – mRNA 1273. Now Moderna shares are around 3% down.

MRNA Stock Down 3%, Moderna Prices New Shares at $76, Wants to Raise $1.34 Billion

Coinspeaker

51 total views, 1 views today

Author: toutiao